X4 Pharmaceuticals
XFOR
XFOR
42 hedge funds and large institutions have $55.3M invested in X4 Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% less funds holding
Funds holding: 51 → 42 (-9)
45% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 20
Holders
42
Holding in Top 10
1
Calls
$1.1M
Puts
$73K
Top Buyers
| 1 | +$7.64M | |
| 2 | +$7.62M | |
| 3 | +$6.4M | |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$5.93M |
| 5 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$5.28M |
Top Sellers
| 1 | -$401K | |
| 2 | -$252K | |
| 3 | -$209K | |
| 4 |
Jane Street
New York
|
-$185K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$152K |
